Abstract P1-13-01: Comparing the Effects of Denosumab and Zoledronic Acid on Pain Interference with Daily Functioning in a Randomized Phase 3 Trial of Patients with Breast Cancer and Bone Metastases

2010 ◽  
Author(s):  
CS Cleeland ◽  
DL Patrick ◽  
L Fallowfield ◽  
M Clemons ◽  
A Lipton ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Pain Interference ◽  
Daily Functioning ◽  
Phase 3

Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases

Bone ◽  
2010 ◽  
Vol 46 ◽  
pp. S36-S37 ◽  
Author(s):  
Jean-Jacques Body ◽  
Alison Stopeck ◽  
Yasuhiro Fujiwara ◽  
Allan Lipton ◽  
Guenther Steger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Phase 3 ◽  
Double Blind

scholarly journals Pain Interference Outcomes in a Randomized Phase 3 Clinical Trial of Denosumab vs Zoledronic Acid (ZA) in Patients with Solid Tumors and Bone Metastases

2012 ◽  
Vol 23 ◽  
pp. ix509-ix510
Author(s):  
C. Cleeland ◽  
L. Fallowfield ◽  
R. von Moos ◽  
D. Patrick ◽  
D.H. Henry ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Zoledronic Acid ◽  
Bone Metastases ◽  
Solid Tumors ◽  
Pain Interference ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document